Key facts
- This page summarizes Deepak Jain's Form 4 filing for PROKIDNEY CORP. (PROK).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 18 Jan 2023, 15:12.
Deepak Jain - 16 Jan 2023 Form 4 Insider Report for PROKIDNEY CORP. (PROK)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- PROK
- Reported as of
- 16 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Jan 2023, 15:12:12 UTC
- Prior SEC filing
- 24 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Todd Girolamo, attorney in fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Deepak Jain filed Form 4 for PROKIDNEY CORP. (PROK) on 18 Jan 2023.
Change
- Previous filing in this sequence was filed on 24 Oct 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PROK
transaction
Derivative
Employee stock option (right to buy)
Award
- Transaction value
- $0
- Shares
- +585,000
- Change %
- Price
- $0.000000
- Shares after
- 585,000
- Date
- 16 Jan 2023
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 585,000
- Exercise price
- $8.43
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vests in substantially equal monthly installments over the four year period beginning on January 16, 2023.